Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAbFh_jLSFfKQUKSi3Wi83NW0Kzypk12Pgm_wi7YOJqTE#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _4 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _4 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _3 provenance.
- assertion hadPrimarySource 15180498 provenance.
- _3 wasQuotedFrom 15180498 provenance.
- _3 value "PI3K/Akt LY294002 kinase inhibitor preclinical Clark et al. 2002 (106) NF-?B PS-341 proteasome inhibitor Phase I and II Adams 2002 (111) Indeed, inhibition of NF-?B by proteasome inhibitor PS-341 is being evaluated in clinical studies for the treatment of refractory hematologic malignancies and as an adjuvant approach in combination with chemotherapy or radiation for a variety of cancers [42, 43]." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.